ArticleThe Journal of clinical endocrinology and metabolism2023

Efficacy and Safety of Osilodrostat in Paraneoplastic Cushing Syndrome: A Real-World Multicenter Study in France.

Alexandre Dormoy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.